Skip to main content
Clinical Trials/JPRN-UMIN000012793
JPRN-UMIN000012793
Completed
未知

Studies on the predictive factors of treatment outcome after intravitreal injection of Lucentis (ranibizumab) in eyes with macular edema associated with central retinal vein occlusion (CRVO) - Effect of ranibizumab in eyes with macular edema associated with CRVO

Ophthalmology, Mie University Hospital0 sites30 target enrollmentJanuary 10, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Central retinal vein occlusion
Sponsor
Ophthalmology, Mie University Hospital
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 10, 2014
End Date
January 31, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ophthalmology, Mie University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Any history of previous treatments for CRVO

Outcomes

Primary Outcomes

Not specified

Similar Trials